Related Experiment Video

Updated: Jun 12, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

[Current aspects of adjuvant therapy of malignant melanoma]

K C Kähler1, F Egberts, A Hauschild

  • 1Klinik für Dermatologie, -Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Schittenhelmstr. 7, 24105, Kiel, Germany. kckaehler@yahoo.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|June 1, 2010
PubMed

Insights

Effective adjuvant treatments for stage IV melanoma are urgently needed. While chemotherapy offers no survival benefit, interferon therapy has shown promise, and new treatments like ipilimumab and MAGE-A3 peptide vaccination are under investigation.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Stage IV melanoma patients have a poor prognosis despite extensive research.
  • Effective adjuvant treatments are crucial to prevent relapse and metastasis in high-risk patients.

Purpose of the Study:

  • To review the current landscape of adjuvant treatment options for stage IV melanoma.
  • To highlight the limitations of traditional chemotherapy and the emergence of novel therapies.

Main Methods:

  • Review of clinical trials and research efforts in adjuvant melanoma treatment.
  • Analysis of treatment benefits and survival outcomes for various therapeutic strategies.

Main Results:

  • Systemic adjuvant chemotherapy has not improved relapse-free or overall survival.
  • Interferon alpha (IFN-α) 2a and 2b demonstrated treatment benefit and gained approval.
  • Current research explores pegylated interferon, CTLA4 inhibitors (ipilimumab), and MAGE-A3 peptide vaccination.

Conclusions:

  • Interferon therapy represents a significant advancement in adjuvant melanoma treatment.
  • Novel immunotherapies and targeted treatments show promise for improving outcomes in stage IV melanoma.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...